Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Amy GilesIncreasing Engagement
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email